Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 731

1.

Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotype.

Zaunders J, Dyer WB, Churchill M, Munier CML, Cunningham PH, Suzuki K, McBride K, Hey-Nguyen W, Koelsch K, Wang B, Hiener B, Palmer S, Gorry PR, Bailey M, Xu Y, Danta M, Seddiki N, Cooper DA, Saksena NK, Sullivan JS, Riminton S, Learmont J, Kelleher AD.

J Virus Erad. 2019 Apr 1;5(2):73-83.

2.

HIV treatment regimens and adherence to national guidelines in Australia: an analysis of dispensing data from the Australian pharmaceutical benefits scheme.

Dharan NJ, Radovich T, Che S, Petoumenos K, Juneja P, Law M, Huang R, McManus H, Polizzotto MN, Guy R, Cronin P, Cooper DA, Gray RT.

BMC Public Health. 2019 Jan 3;19(1):13. doi: 10.1186/s12889-018-6325-5.

3.

HIV-1 DNA Is Maintained in Antigen-Specific CD4+ T Cell Subsets in Patients on Long-Term Antiretroviral Therapy Regardless of Recurrent Antigen Exposure.

Hey-Nguyen WJ, Bailey M, Xu Y, Suzuki K, Van Bockel D, Finlayson R, Leigh Brown A, Carr A, Cooper DA, Kelleher AD, Koelsch KK, Zaunders JJ.

AIDS Res Hum Retroviruses. 2019 Jan;35(1):112-120. doi: 10.1089/AID.2018.0235.

PMID:
30511878
4.

Implications of Image-Defined Risk Factors and Primary-Site Response on Local Control and Radiation Treatment Delivery in the Management of High-Risk Neuroblastoma: Is There a Role for De-escalation of Adjuvant Primary-Site Radiation Therapy?

Lucas JT Jr, McCarville MB, Cooper DA, Doubrovin M, Wakefield D, Santiago T, Li Y, Li X, Krasin M, Santana V, Furman W, Davidoff AM.

Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):869-877. doi: 10.1016/j.ijrobp.2018.11.041. Epub 2018 Nov 26.

PMID:
30496881
5.

Cardiovascular disease and diabetes in HIV-positive and HIV-negative gay and bisexual men over the age of 55 years in Australia: insights from the Australian Positive & Peers Longevity Evaluation Study.

Puhr R, Petoumenos K, Huang R, Templeton DJ, Woolley I, Bloch M, Russell D, Law MG, Cooper DA.

HIV Med. 2019 Feb;20(2):121-130. doi: 10.1111/hiv.12689. Epub 2018 Nov 26.

PMID:
30474916
6.

Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study.

Grulich AE, Guy R, Amin J, Jin F, Selvey C, Holden J, Schmidt HA, Zablotska I, Price K, Whittaker B, Chant K, Cooper C, McGill S, Telfer B, Yeung B, Levitt G, Ogilvie EE, Dharan NJ, Hammoud MA, Vaccher S, Watchirs-Smith L, McNulty A, Smith DJ, Allen DM, Baker D, Bloch M, Bopage RI, Brown K, Carr A, Carmody CJ, Collins KL, Finlayson R, Foster R, Jackson EY, Lewis DA, Lusk J, O'Connor CC, Ryder N, Vlahakis E, Read P, Cooper DA; Expanded PrEP Implementation in Communities New South Wales (EPIC-NSW) research group.

Lancet HIV. 2018 Nov;5(11):e629-e637. doi: 10.1016/S2352-3018(18)30215-7. Epub 2018 Oct 17.

PMID:
30343026
7.

The cascade of HIV care among key populations in Indonesia: a prospective cohort study.

Januraga PP, Reekie J, Mulyani T, Lestari BW, Iskandar S, Wisaksana R, Kusmayanti NA, Subronto YW, Widyanthini DN, Wirawan DN, Wongso LV, Sudewo AG, Sukmaningrum E, Nisa T, Prabowo BR, Law M, Cooper DA, Kaldor JM.

Lancet HIV. 2018 Oct;5(10):e560-e568. doi: 10.1016/S2352-3018(18)30148-6. Epub 2018 Aug 22.

PMID:
30143455
8.

Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study.

Bavinton BR, Pinto AN, Phanuphak N, Grinsztejn B, Prestage GP, Zablotska-Manos IB, Jin F, Fairley CK, Moore R, Roth N, Bloch M, Pell C, McNulty AM, Baker D, Hoy J, Tee BK, Templeton DJ, Cooper DA, Emery S, Kelleher A, Grulich AE; Opposites Attract Study Group.

Lancet HIV. 2018 Aug;5(8):e438-e447. doi: 10.1016/S2352-3018(18)30132-2. Epub 2018 Jul 17. Erratum in: Lancet HIV. 2018 Oct;5(10):e545.

PMID:
30025681
9.

Correlation Between mMINDS and CIWA-Ar Scoring Tools in Patients With Alcohol Withdrawal Syndrome.

Littlefield AJ, Heavner MS, Eng CC, Cooper DA, Heavner JJ, Kurtz JM, Pisani MA.

Am J Crit Care. 2018 Jul;27(4):280-286. doi: 10.4037/ajcc2018547.

10.

Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality.

Pinto AN, Grey P, Shaik A, Cooper DA, Kelleher AD, Petoumenos K.

AIDS Res Hum Retroviruses. 2018 Nov;34(11):936-941. doi: 10.1089/AID.2017.0284. Epub 2018 Jul 17.

PMID:
29901415
11.

National characteristics and trends in antiretroviral treatment in Australia can be accurately estimated using a large clinical cohort.

Huang R, Petoumenos K, Gray RT, McManus H, Dharan N, Guy R, Cooper DA.

J Clin Epidemiol. 2018 Aug;100:82-91. doi: 10.1016/j.jclinepi.2018.04.015. Epub 2018 Apr 25.

12.

The 2016 HIV diagnosis and care cascade in New South Wales, Australia: meeting the UNAIDS 90-90-90 targets.

Keen P, Gray RT, Telfer B, Guy R, Schmidt HM, Whittaker B, Holden J, Holt M, Kelleher A, Wilson D, Callander D, Cooper DA, Prestage G, Selvey C, Grulich AE; NSW HIV Prevention Partnership Project.

J Int AIDS Soc. 2018 Apr;21(4):e25109. doi: 10.1002/jia2.25109.

13.

Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial.

Arenas-Pinto A, Grund B, Sharma S, Martinez E, Cummins N, Fox J, Klingman KL, Sedlacek D, Collins S, Flynn PM, Chasanov WM, Kedem E, Katlama C, Sierra-Madero J, Afonso C, Brouwers P, Cooper DA; INSIGHT START study group.

Clin Infect Dis. 2018 Jul 18;67(3):420-429. doi: 10.1093/cid/ciy051.

14.

Flow Preservation of Umbilical Vein for Autologous Shunt and Cardiovascular Reconstruction.

Hoganson DM, Cooper DA, Rich KN, Piekarski BL, Gui L, Gaut JP, Mayer JE, Aikawa E, Niklason LE, Emani SM.

Ann Thorac Surg. 2018 Jun;105(6):1809-1818. doi: 10.1016/j.athoracsur.2018.01.076. Epub 2018 Mar 3.

15.

Correction: expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in new South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial.

Zablotska IB, Selvey C, Guy R, Price K, Holden J, Schmidt HM, McNulty A, Smith D, Jin F, Amin J, Cooper DA, Grulich AE; EPIC-NSW study group.

BMC Public Health. 2018 Feb 28;18(1):297. doi: 10.1186/s12889-018-5173-7.

16.

The clinical characteristics of adults with rheumatic heart disease in Yangon, Myanmar: An observational study.

Myint NPST, Aung NM, Win MS, Htut TY, Ralph AP, Cooper DA, Nyein ML, Kyi MM, Hanson J.

PLoS One. 2018 Feb 21;13(2):e0192880. doi: 10.1371/journal.pone.0192880. eCollection 2018.

17.

Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial.

Zablotska IB, Selvey C, Guy R, Price K, Holden J, Schmidt HM, McNulty A, Smith D, Jin F, Amin J, Cooper DA, Grulich AE; EPIC-NSW study group.

BMC Public Health. 2018 Feb 2;18(1):210. doi: 10.1186/s12889-017-5018-9. Erratum in: BMC Public Health. 2018 Feb 28;18(1):297.

18.

High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years.

McMahon CN, Petoumenos K, Hesse K, Carr A, Cooper DA, Samaras K.

AIDS. 2018 Feb 20;32(4):451-459. doi: 10.1097/QAD.0000000000001709. Erratum in: AIDS. 2018 Sep 24;32(15):2267.

PMID:
29381559
19.

Genome-Wide circRNA Profiling from RNA-seq Data.

Cooper DA, Cortés-López M, Miura P.

Methods Mol Biol. 2018;1724:27-41. doi: 10.1007/978-1-4939-7562-4_3.

20.

Combination ART: are two drugs as good as three?

Boyd MA, Cooper DA.

Lancet. 2018 Mar 3;391(10123):817-819. doi: 10.1016/S0140-6736(18)30008-4. Epub 2018 Jan 6. No abstract available.

PMID:
29310898
21.

Relationship between untimed plasma lopinavir concentrations and virological outcome on second-line antiretroviral therapy.

Mwasakifwa GE, Moore C, Carey D, Amin J, Penteado P, Losso M, Lim PL, Mohapi L, Molina JM, Gazzard B, Cooper DA, Boyd M; SECOND-LINE Study Group.

AIDS. 2018 Jan 28;32(3):357-361. doi: 10.1097/QAD.0000000000001688. Erratum in: AIDS. 2018 Mar 13;32(5):683.

PMID:
29309346
22.

Global accumulation of circRNAs during aging in Caenorhabditis elegans.

Cortés-López M, Gruner MR, Cooper DA, Gruner HN, Voda AI, van der Linden AM, Miura P.

BMC Genomics. 2018 Jan 3;19(1):8. doi: 10.1186/s12864-017-4386-y.

23.

Transcriptome profiling of aging Drosophila photoreceptors reveals gene expression trends that correlate with visual senescence.

Hall H, Medina P, Cooper DA, Escobedo SE, Rounds J, Brennan KJ, Vincent C, Miura P, Doerge R, Weake VM.

BMC Genomics. 2017 Nov 21;18(1):894. doi: 10.1186/s12864-017-4304-3.

24.

Reducing medical comorbidities associated with long-term HIV infection: beyond optimizing antiretroviral therapy regimens.

Dharan NJ, Cooper DA.

AIDS. 2017 Nov 28;31(18):2547-2549. doi: 10.1097/QAD.0000000000001677. No abstract available.

PMID:
29120900
25.

HIV dynamics linked to memory CD4+ T cell homeostasis.

Murray JM, Zaunders J, Emery S, Cooper DA, Hey-Nguyen WJ, Koelsch KK, Kelleher AD.

PLoS One. 2017 Oct 19;12(10):e0186101. doi: 10.1371/journal.pone.0186101. eCollection 2017.

26.

Towards a universal second-line fixed-dose combination ART.

Boyd MA, Cooper DA, Gilks CF.

Lancet HIV. 2018 Jan;5(1):e3-e5. doi: 10.1016/S2352-3018(17)30180-7. Epub 2017 Oct 6. No abstract available.

PMID:
28993181
27.

Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years-The Australian Positive & Peers Longevity Evaluation Study (APPLES).

Petoumenos K, Huang R, Hoy J, Bloch M, Templeton DJ, Baker D, Giles M, Law MG, Cooper DA.

PLoS One. 2017 Sep 8;12(9):e0184583. doi: 10.1371/journal.pone.0184583. eCollection 2017.

28.

Prognostic Relevance of Treatment Failure Patterns in Pediatric High-Grade Glioma: Is There a Role for a Revised Failure Classification System?

Lucas JT Jr, Cooper DA, Hwang S, Tinkle C, Li X, Li Y, Orr B, Merchant TE, Broniscer A.

Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):450-458. doi: 10.1016/j.ijrobp.2017.04.039. Epub 2017 May 4.

PMID:
28871996
29.

Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis.

Kanters S, Socias ME, Paton NI, Vitoria M, Doherty M, Ayers D, Popoff E, Chan K, Cooper DA, Wiens MO, Calmy A, Ford N, Nsanzimana S, Mills EJ.

Lancet HIV. 2017 Oct;4(10):e433-e441. doi: 10.1016/S2352-3018(17)30109-1. Epub 2017 Aug 4. Review.

PMID:
28784426
30.

The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.

Thit SS, Aung NM, Htet ZW, Boyd MA, Saw HA, Anstey NM, Kyi TT, Cooper DA, Kyi MM, Hanson J.

BMC Med. 2017 Aug 4;15(1):145. doi: 10.1186/s12916-017-0888-3.

31.

Long-acting injectable ART: next revolution in HIV?

Boyd MA, Cooper DA.

Lancet. 2017 Sep 23;390(10101):1468-1470. doi: 10.1016/S0140-6736(17)31962-1. Epub 2017 Jul 24. No abstract available.

PMID:
28750936
32.

Chronic kidney disease in Australian Human Immunodeficiency Virus-infected patients: Analysis of the Australian HIV Observational Database.

Cheung J, Puhr R, Petoumenos K, Cooper DA, Woolley I, Gunathilake M, Raymond N, Varma R, O'Connor CC, Gracey DM.

Nephrology (Carlton). 2018 Aug;23(8):778-786. doi: 10.1111/nep.13100.

33.

Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption.

Lee WS, Kristensen AB, Rasmussen TA, Tolstrup M, Østergaard L, Søgaard OS, Wines BD, Hogarth PM, Reynaldi A, Davenport MP, Emery S, Amin J, Cooper DA, Kan VL, Fox J, Gruell H, Parsons MS, Kent SJ.

J Virol. 2017 Jul 12;91(15). pii: e00603-17. doi: 10.1128/JVI.00603-17. Print 2017 Aug 1.

34.

HIV-1 and SIV Predominantly Use CCR5 Expressed on a Precursor Population to Establish Infection in T Follicular Helper Cells.

Xu Y, Phetsouphanh C, Suzuki K, Aggrawal A, Graff-Dubois S, Roche M, Bailey M, Alcantara S, Cashin K, Sivasubramaniam R, Koelsch KK, Autran B, Harvey R, Gorry PR, Moris A, Cooper DA, Turville S, Kent SJ, Kelleher AD, Zaunders J.

Front Immunol. 2017 Apr 21;8:376. doi: 10.3389/fimmu.2017.00376. eCollection 2017.

35.

Long-term durability of HIV viral load suppression.

Dharan NJ, Cooper DA.

Lancet HIV. 2017 Jul;4(7):e279-e280. doi: 10.1016/S2352-3018(17)30063-2. Epub 2017 May 4. No abstract available.

36.

Evolution of HIV-1 surveillance drug resistance mutations over ten years in New South Wales, Australia.

Pinto A, Carrera A, Salem H, Thapa K, Shaik A, Petoumenos K, Cunningham P, Garsia R, Dwyer D, Cooper DA, Kelleher AD.

AIDS Res Hum Retroviruses. 2017 May 5. doi: 10.1089/AID.2016.0301. [Epub ahead of print]

PMID:
28474534
37.

Metabolic profiles of individuals switched to second-line antiretroviral therapy after failing standard first-line therapy for treatment of HIV-1 infection in a randomized, controlled trial.

Yao AH, Moore CL, Lim PL, Molina JM, Madero JS, Kerr S, Mallon PW, Emery S, Cooper DA, Boyd MA; SECOND-LINE study group.

Antivir Ther. 2018;23(1):21-32. doi: 10.3851/IMP3171.

PMID:
28447585
38.

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration.

Rhee SY, Varghese V, Holmes SP, Van Zyl GU, Steegen K, Boyd MA, Cooper DA, Nsanzimana S, Saravanan S, Charpentier C, de Oliveira T, Etiebet MA, Garcia F, Goedhals D, Gomes P, Günthard HF, Hamers RL, Hoffmann CJ, Hunt G, Jiamsakul A, Kaleebu P, Kanki P, Kantor R, Kerschberger B, Marconi VC, D'amour Ndahimana J, Ndembi N, Ngo-Giang-Huong N, Rokx C, Santoro MM, Schapiro JM, Schmidt D, Seu L, Sigaloff KCE, Sirivichayakul S, Skhosana L, Sunpath H, Tang M, Yang C, Carmona S, Gupta RK, Shafer RW.

EBioMedicine. 2017 Apr;18:225-235. doi: 10.1016/j.ebiom.2017.03.024. Epub 2017 Mar 19.

39.

Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals.

Koelsch KK, Rasmussen TA, Hey-Nguyen WJ, Pearson C, Xu Y, Bailey M, Marks KH, Sasson SC, Taylor MS, Tantau R, Obeid S, Milner B, Morrissey O, Pinto AN, Suzuki K, Busch MP, Keating SM, Kaiser P, Yukl S, Wong JK, Hiener BM, Palmer S, Zaunders J, Post JJ, Chan DJ, Avery S, Milliken ST, Kelleher AD, Lewin SR, Cooper DA.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):328-337. doi: 10.1097/QAI.0000000000001381.

40.

Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts.

Madhavi V, Kulkarni A, Shete A, Lee WS, Mclean MR, Kristensen AB, Ghate M, Wines BD, Hogarth PM, Parsons MS, Kelleher A, Cooper DA, Amin J, Emery S, Thakar M, Kent SJ; ENCORE1 Study Group.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):345-353. doi: 10.1097/QAI.0000000000001380.

PMID:
28346319
41.

Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes During Antiretroviral Therapy.

Hey-Nguyen WJ, Xu Y, Pearson CF, Bailey M, Suzuki K, Tantau R, Obeid S, Milner B, Field A, Carr A, Bloch M, Cooper DA, Kelleher AD, Zaunders JJ, Koelsch KK.

AIDS Res Hum Retroviruses. 2017 Jul;33(7):648-657. doi: 10.1089/aid.2016.0171. Epub 2017 Mar 13.

PMID:
28287825
42.

HIV care in Yangon, Myanmar; successes, challenges and implications for policy.

Aung NM, Hanson J, Kyi TT, Htet ZW, Cooper DA, Boyd MA, Kyi MM, Saw HA.

AIDS Res Ther. 2017 Mar 4;14(1):10. doi: 10.1186/s12981-017-0137-z.

43.

Furanyl Cyclic Ethers: Single and Double Diastereoselectivity in the Synthesis of 2,4-Di and 2,4,5-Trisubstituted Tetrahydropyrans.

Cooper DA, Robbins E, Tizzard GJ, Coles SJ, O'Brien M.

J Org Chem. 2017 Apr 7;82(7):3441-3455. doi: 10.1021/acs.joc.6b02831. Epub 2017 Mar 16.

PMID:
28244750
44.

Managing two decades of visceral leishmaniasis and HIV co-infection: a case report that illustrates the urgent research needs in the field.

Kelly ML, Pinto AN, Suan D, Marriott D, Cooper DA, Pett SL.

Sex Health. 2017 Jun;14(3):286-288. doi: 10.1071/SH16036.

PMID:
28063460
45.

CircRNA accumulation in the aging mouse brain.

Gruner H, Cortés-López M, Cooper DA, Bauer M, Miura P.

Sci Rep. 2016 Dec 13;6:38907. doi: 10.1038/srep38907.

46.

A longitudinal cohort study of HIV 'treatment as prevention' in gay, bisexual and other men who have sex with men: the Treatment with Antiretrovirals and their Impact on Positive And Negative men (TAIPAN) study protocol.

Callander D, Stoové M, Carr A, Hoy JF, Petoumenos K, Hellard M, Elliot J, Templeton DJ, Liaw S, Wilson DP, Grulich A, Cooper DA, Pedrana A, Donovan B, McMahon J, Prestage G, Holt M, Fairley CK, McKellar-Stewart N, Ruth S, Asselin J, Keen P, Cooper C, Allan B, Kaldor JM, Guy R.

BMC Infect Dis. 2016 Dec 12;16(1):752.

47.

CD4+ T Follicular Helper and IgA+ B Cell Numbers in Gut Biopsies from HIV-Infected Subjects on Antiretroviral Therapy Are Similar to HIV-Uninfected Individuals.

Zaunders J, Danta M, Bailey M, Mak G, Marks K, Seddiki N, Xu Y, Templeton DJ, Cooper DA, Boyd MA, Kelleher AD, Koelsch KK.

Front Immunol. 2016 Oct 24;7:438. eCollection 2016.

48.

Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.

Boyd MA, Amin J, Mallon PW, Kumarasamy N, Lombaard J, Wood R, Chetchotisakd P, Phanuphak P, Mohapi L, Azwa I, Belloso WH, Molina JM, Hoy J, Moore CL, Emery S, Cooper DA; SECOND-LINE Study Group.

Lancet HIV. 2017 Jan;4(1):e13-e20. doi: 10.1016/S2352-3018(16)30189-8. Epub 2016 Nov 1.

PMID:
27815068
49.

Comparative analysis of anti-polyglutamine Fab crystals grown on Earth and in microgravity.

Owens GE, New DM, Olvera AI, Manzella JA, Macon BL, Dunn JC, Cooper DA, Rouleau RL, Connor DS, Bjorkman PJ.

Acta Crystallogr F Struct Biol Commun. 2016 Oct 1;72(Pt 10):762-771. Epub 2016 Sep 22.

50.

The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype.

Munier CML, van Bockel D, Bailey M, Ip S, Xu Y, Alcantara S, Liu SM, Denyer G, Kaplan W; PHIIDO Study group, Suzuki K, Croft N, Purcell A, Tscharke D, Cooper DA, Kent SJ, Zaunders JJ, Kelleher AD.

Vaccine. 2016 Oct 17;34(44):5251-5261. doi: 10.1016/j.vaccine.2016.09.009. Epub 2016 Sep 14.

PMID:
27639281

Supplemental Content

Loading ...
Support Center